$108.820
-5.909 (-5.43%)收盘时
MANE 同业对比
In the context of the broader market, MANE competes directly with industry leaders such as TVTX and ERAS. With a market capitalization of $4.81B, it holds a significant position in the sector. When comparing efficiency, MANE's gross margin of N/A stands against TVTX's 88.96% and ERAS's N/A. Such benchmarking helps identify whether Veradermics, Incorporated is trading at a premium or discount relative to its financial performance.
Veradermics Inc 财务表现
The company has shown a significant increase in total equity, rising from $39,064,000 in Q1 2026 to $81,361,300 in Q2 2026, indicating improving financial health despite ongoing losses.
Financials
FY2026Q2
YoY:
+83.87%
-29.55M
Operating Profit
FY2026Q2
YoY:
+50.22%
-23.50M
Net Income after Tax
FY2026Q2
YoY:
+13.73%
-0.58
EPS - Diluted
FY2026Q2
YoY:
-7.24%
-14.51M
Free Cash Flow
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。